Article Details

New Phase III Data Reaffirms Tezepelumab's Potential for Severe Asthma | BioSpace

Retrieved on: 2021-09-07 17:09:13

Tags for this article:

Click the tags to see associated articles and topics

New Phase III Data Reaffirms Tezepelumab's Potential for Severe Asthma | BioSpace. View article details on hiswai:

Excerpt

Tezepelumab, an injectable subcutaneous monoclonal antibody, is one of the more advanced monoclonal antibodies that blocks TSLP. Recent clinical and ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up